Insight in North America

The following industries match your search criteria:

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Click here to sort results by relevance. Click on heading titles to sort results by different field.

Type Product title / description Pub Price
Report
Report

Big Pharma Mega-Mergers 1995-2014

Revenue and financial performance analysis of the 22 largest Big Pharma M&A events since 1995.

Published By Datamonitor
10 Dec 2009 $7600
Buy

Exclusive online offer: order this report by November 9th and save 20%

To take advantage of this offer enter Promo Code BIO2012 when prompted in the checkout

More information

Report
Report

Biosimilars: Market Entry Strategies

This report provides an analysis of strategies employed by the top 50 pharma companies that are active or plan to enter the biosimilars sector in the future, together with an analysis of biosimilar deal trends among the top 50 pharma companies.

Published By Datamonitor
20 Dec 2011 $5700
Buy
Brief
Brief

BP Sustainability Case Study

The way oil and gas companies respond to complex sustainability issues is crucial to future energy supply. This brief analyses in-depth how BP responds to those issues and outlines three scenarios for their corporate strategy to 2030.

Published By Datamonitor
29 Jul 2010 $3495
Buy
Report
Report

Branching Out: Rebuilding Value in the Branch Channel

This report is the first in the global customer experience series, and looks at the branch channel. It examines the latest developments in branch networks, and assesses future prospects for branches in a multi-channel environment.

Published By Datamonitor
15 Jun 2010 $4495
Buy
Report
Report

Canada: Generics and Biosimilars Overview

Overview of the generics and biosimilars landscape including, regulatory issues, drivers and resistors to uptake, level of penetration, and key players operating in the market.

Published By Datamonitor
03 Nov 2011 $1900
Buy
Report
Report

Canada: Healthcare System and Drug Regulatory Overview

This report provides an overview of the insurance and healthcare system, healthcare reforms, drug regulation and intellectual property, and drug pricing and reimbursement in Canada.

Published By Datamonitor
15 Dec 2011 $1900
Buy
Report
Report

Canada: Pharmaceutical Industry Infrastructure Overview

This report provides an overview of research and development, manufacturing, outsourcing, and distribution trends, as well as infrastructure profiles for the leading pharmaceutical companies in Canada.

Published By Datamonitor
16 Dec 2011 $1900
Buy
Report
Report

Case Study: Autism Spectrum Disorders – Public awareness and physician detailing will drive market growth

This report examines the opportunities and threats within the autism spectrum disorders (ASDs) market. The analysis is intended to support company strategy and decision-making by providing actionable recommendations in the current treatment pathway.

Published By Datamonitor
16 Apr 2012 $1900
Buy
Report
Report

Case Study: HIV - Better differential pricing strategies are needed to ensure access to HIV drugs

This module discusses differential pricing for antiretrovirals as a strategy that enhances access to drugs while preserving incentives for pharmaceutical companies.

Published By Datamonitor
18 May 2011 $1900
Buy
Brief
Brief

Chase Case Study: Innovative Customer Retention in the Cards Market

The introduction of Chase's Blueprint campaign - an offering which allows consumers to take control of their finances and pay debt faster - has injected the credit card industry with some much needed innovation in terms of retaining the consumer.

Published By Datamonitor
08 Jun 2010 $1695
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.